ClearPoint Neuro Inc (CLPT)
6.195
-0.20
(-3.20%)
USD |
NASDAQ |
May 17, 16:00
6.195
0.00 (0.00%)
After-Hours: 20:00
ClearPoint Neuro Cash from Financing (TTM): 16.35M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 16.35M |
December 31, 2023 | 0.296M |
September 30, 2023 | 0.363M |
June 30, 2023 | 0.125M |
March 31, 2023 | 0.401M |
December 31, 2022 | 0.409M |
September 30, 2022 | 0.235M |
June 30, 2022 | 0.112M |
March 31, 2022 | -0.052M |
December 31, 2021 | 46.88M |
September 30, 2021 | 54.70M |
June 30, 2021 | 55.16M |
March 31, 2021 | 55.57M |
December 31, 2020 | 22.69M |
September 30, 2020 | 14.74M |
June 30, 2020 | 14.49M |
March 31, 2020 | 19.66M |
December 31, 2019 | 5.605M |
September 30, 2019 | 5.651M |
June 30, 2019 | 3.904M |
March 31, 2019 | -1.700M |
December 31, 2018 | -1.495M |
September 30, 2018 | -1.459M |
Date | Value |
---|---|
June 30, 2018 | 0.5318M |
March 31, 2018 | 12.20M |
December 31, 2017 | 11.99M |
September 30, 2017 | 11.98M |
June 30, 2017 | 15.82M |
March 31, 2017 | 3.968M |
December 31, 2016 | 3.828M |
September 30, 2016 | 8.712M |
June 30, 2016 | 4.879M |
March 31, 2016 | 4.739M |
December 31, 2015 | 4.879M |
September 30, 2015 | 9.380M |
June 30, 2015 | 9.380M |
March 31, 2015 | 9.380M |
December 31, 2014 | 13.03M |
September 30, 2014 | 3.646M |
June 30, 2014 | 3.653M |
March 31, 2014 | 3.666M |
December 31, 2013 | 9.849M |
September 30, 2013 | 9.942M |
June 30, 2013 | 14.46M |
March 31, 2013 | 15.44M |
December 31, 2012 | 9.036M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.052M
Minimum
Mar 2022
55.57M
Maximum
Mar 2021
15.86M
Average
5.628M
Median
Cash from Financing (TTM) Benchmarks
icad Inc | -- |
Perspective Therapeutics Inc | 167.19M |
Xtant Medical Holdings Inc | 20.30M |
Asensus Surgical Inc | 10.92M |
Catheter Precision Inc | -0.158M |